HOME HELP FEEDBACK SUBSCRIPTIONS ALL ISSUES SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burton, E. J. Articles by O'Brien, J. T. Search for Related Content PubMed PubMed Citation Articles by Burton, E. J. Articles by O'Brien, J. T.

Progression of White Matter Hyperintensities in Alzheimer Disease, Dementia With Lewy Bodies, and Parkinson Disease Dementia: A Comparison With Normal Aging

From the Institute for Ageing and Health, Wolfson Research Centre (EJB, IGM, MJF, JTO) and the Department of Neurology, Regional Neurosciences Centre (DJB), Newcastle General Hospital, Newcastle upon Tyne, U.K.

Objective: The objective of this study was to investigate cross-sectional and longitudinal white matter hyperintensity (WMH) changes in older subjects with clinically diagnosed dementia.

Methods: Fluid-attenuated inversion recovery images were acquired one year apart in subjects with dementia with Lewy bodies (DLB), Parkinson disease dementia (PDD), Alzheimer disease (AD), and also healthy elderly comparison subjects. WMH volume was quantified using an automated technique.

Results: Baseline WMH (as a percent of brain volume) was significantly greater compared with healthy subjects (N=33, geometric mean WMH: 0.4%) in subjects with AD (N=23 [1.3%], analysis of variance post hoc p <0.001) but not PDD (N=13 [0.6%]) or DLB (N=14 [0.4%]). Increase in WMH volume (as a percent of brain volume) was not significantly different (Kruskal-Wallis p=0.4) between groups (AD median change: 0.08%; DLB: 0.025%; PDD: 0.07%, healthy: 0.02%). Severity of baseline WMH, rather than diagnosis or severity of dementia, was a significant predictor of lesion progression. Rate of change of WMH had no association with change in global cognitive performance.

Conclusions: Significant WMH progression occurs in degenerative dementias with rates influenced by severity of lesions at baseline rather than dementia type or cognitive decline.

Key Words: White matter hyperintensities • dementia • MRI

This article has been cited by other articles:

				C. M. Holland, E. E. Smith, I. Csapo, M. E. Gurol, D. A. Brylka, R. J. Killiany, D. Blacker, M. S. Albert, C. R.G. Guttmann, and S. M. Greenberg Spatial Distribution of White-Matter Hyperintensities in Alzheimer Disease, Cerebral Amyloid Angiopathy, and Healthy Aging Stroke, April 1, 2008; 39(4): 1127 - 1133. [Abstract] [Full Text] [PDF]

				S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF]

				C. F. Lippa, B. F. Boeve, J. E. Parisi, and B. M. Keegan A 75-year-old man with cognitive impairment and gait changes Neurology, September 11, 2007; 69(11): 1183 - 1189. [Full Text] [PDF]

				R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas Progression of Leukoaraiosis and Cognition Stroke, September 1, 2007; 38(9): 2619 - 2625. [Abstract] [Full Text] [PDF]

				G. S. Smith and L. T. Eyler Structural Neuroimaging in Geriatric Psychiatry Am J Geriatr Psychiatry, October 1, 2006; 14(10): 809 - 811. [Full Text] [PDF]